| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.91B | +23.6% |
| Cost of Revenue | $408.5M | +20.4% |
| Gross Profit | $1.50B | +24.5% |
| R&D Expense | $359.7M | -7.2% |
| SG&A Expense | $596.3M | -2.5% |
| Operating Income | -$161.2M | +60.8% |
| Interest Expense | $4.1M | +11.5% |
| Pre-tax Income | -$361.0M | +26.1% |
| Income Tax | $10.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.60B | +13.4% |
| Short-term Investments | $35.1M | -85.0% |
| Accounts Receivable | $258.3M | +35.3% |
| Current Assets | $3.04B | +6.2% |
| Total Assets | $3.46B | +6.6% |
| Current Liabilities | $587.9M | -10.9% |
| Total Liabilities | $818.8M | -14.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $223.7M | -33.0% |
| Capital Expenditures | $40.0M | +217.0% |
| Investing Cash Flow | -$45.4M | +88.6% |
| Financing Cash Flow | $86.0M | -72.0% |
| Free Cash Flow | $183.7M | -42.8% |
| -68.4% |
| Net Income | -$373.7M | +28.2% |
| EPS (Basic) | -$0.18 | +33.3% |
| EPS (Diluted) | -$0.18 | +33.3% |
| Stockholders' Equity |
| $2.57B |
| +12.0% |